“The acquisition of this commercial business aligns with and advances our mission to improve access to innovative and differentiated options that impact women’s daily lives. Solosec is a commercially attractive, single-dose oral antibiotic that addresses two pervasive sexual health infections.," said Saundra Pelletier, Chief Executive Officer, Evofem.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/T6UKwWL
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment